Literature DB >> 31177813

A systematic review of factors that influence the efficacy of cognitive remediation therapy in schizophrenia.

Maree P Reser1, Reneta Slikboer1, Susan L Rossell1,2.   

Abstract

OBJECTIVE: Cognitive remediation therapy is a moderately effective intervention for ameliorating cognitive deficits in individuals with schizophrenia-related disorders. With reports of considerable variability in individual response to cognitive remediation therapy, we need to better understand factors that influence cognitive remediation therapy efficacy to realise its potential. A systematic review was conducted to identify and evaluate predictors of cognitive outcome.
METHODS: An electronic database search was conducted identifying peer-reviewed articles examining predictors of cognitive response to cognitive remediation therapy.
RESULTS: A total of 40 articles accounting for 1681 cognitive remediation therapy participants were included; 81 distinct predictors of cognitive response were identified. Data synthesis and discussion focused on 20 predictors examined a minimum three times in different studies. Few of the examined predictors of cognitive outcome following cognitive remediation therapy were significant when examined through systematic review. A strong trend was found for baseline cognition, with reasoning and problem solving and working memory being strongly predictive of within-domain improvement. Training task progress was the most notable cross-domain predictor of cognitive outcome.
CONCLUSION: It remains unclear why a large proportion of participants fail to realise cognitive benefit from cognitive remediation therapy. However, when considering only those variables where a majority of articles reported a statistically significant association with cognitive response to cognitive remediation therapy, three stand out: premorbid IQ, baseline cognition and training task progress. Each of these relates in some way to an individual's capacity or potential for change. There is a need to consolidate investigation of potential predictors of response to cognitive remediation therapy, strengthening the evidence base through replication and collaboration.

Entities:  

Keywords:  Schizophrenia; cognition; cognitive remediation

Mesh:

Year:  2019        PMID: 31177813     DOI: 10.1177/0004867419853348

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  6 in total

Review 1.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Predictors of Long-Term Improvement Following Cognitive Remediation in a Sample With Elevated Depressive Symptoms.

Authors:  Bjørn Ingulfsvann Hagen; Nils Inge Landrø; Bjørn Lau; Ernst H W Koster; Jan Stubberud
Journal:  Front Psychol       Date:  2020-09-11

3.  Predicting response to cognitive training for schizophrenia using results from two studies with different outcomes.

Authors:  Alice M Saperstein; C Jean Choi; Carol Jahshan; David A Lynch; Melanie Wall; Michael F Green; Alice Medalia
Journal:  Schizophr Res       Date:  2021-03-23       Impact factor: 4.939

4.  The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore.

Authors:  Nigel Ian Ming Chong; Yogeswary Maniam; Yi Chian Chua; Charmaine Tang
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

Review 5.  Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.

Authors:  Giulia M Giordano; Francesco Brando; Pasquale Pezzella; Maria De Angelis; Armida Mucci; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435

6.  Free Thyroxine Concentrations Moderate the Response to a Cognitive Remediation Therapy in People With Early Psychosis: A Pilot Randomized Clinical Trial.

Authors:  Francesc Estrada; Josep Maria Crosas; Maribel Ahuir; Sara Pérez-Muñoz; Wanda Zabala; Raquel Aguayo; Juan David Barbero; Itziar Montalvo; Meritxell Tost; Laura Llauradó; Armand Guardia; Diego Palao; José Antonio Monreal; Javier Labad
Journal:  Front Psychiatry       Date:  2020-07-07       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.